DIRECT ORAL ANTI-COAGULANT (DOAC) MEASUREMENT FOCUSING ON ANTI-XA, AND RECENT DOAC TRIAL UPDATES
April 22, 2019 | (12.00 PM)
USA (United States of America)
Have you ever wondered about the impact of direct oral anticoagulants (DOACs) on routine coagulation assays and how patients on DOACs can be managed by the clinical laboratory? DOACs have been available for several years to treat atrial fibrillation patients at risk of stroke, as well as patients with venous thromboembolism (VTE). Though routine monitoring is not required for patients taking DOACs, screening or measurement assays could help in some emergency patient management situations. Dr. Crowther’s webinar will cover this hot topic, which regularly impacts patients in critical care settings.